Fluorochemicals in food packaging
High performance liquid chromatography?mass spectrometry (HPLC?MS) was used by Danish scientists to identify a potential hazard associated with new fluorinated chemicals widely found in many food packaging materials, including microwave popcorn bags and pizza boxes, according to a study in Toxicology and Applied Pharmacology.1 The chemicals have been implicated in the disruption of androgen synthesis.
High performance liquid chromatography–mass spectrometry (HPLC–MS) was used by Danish scientists to identify a potential hazard associated with new fluorinated chemicals widely found in many food packaging materials, including microwave popcorn bags and pizza boxes, according to a study in Toxicology and Applied Pharmacology.1 The chemicals have been implicated in the disruption of androgen synthesis.
Currently there is no European legislation regarding polyfluoroalkyl phosphate esters (PAPS) for paper and board food contact materials (FCM). This is despite other studies in the United States that have discovered that the human intestinal tract absorbs PAPs and that they can persist within the body for a number of years, according to the paper. Co-author of the study, Anne Marie Vinggaard, of the Technical University of Denmark, told The Column: “These chemicals are highly persistent, meaning that it takes years before they are excreted from the human body following exposure. Besides PFOA, diPAPS have been measured in human blood.”
HPLC–MS was performed by the team to analyse the levels of hormones excreted from cells following exposure to four specific chemicals — 8:2 monoPAPS, 8:2 diPAPS,10:2 diPAPS, and 8.2 triPAPS — to determine their toxicological effects on androgen synthesis and its effector pathways. Vinggaard told The Column that this is highly relevant as the signalling mechanisms are involved in the development of the male foetus, and that these chemicals may cause adverse effects on male development in animal experiments. Future studies are planned to determine if there is a risk to humans.
Reference
1. A.K. Rosenmai et al, Toxicology and Applied Pharmacology266, 132–142 (2013).
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
